Published Date: 13 Mar 2023
OSA itself predicted the incidence of MACCE in non-obese patients.
Read Full NewsA trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.
State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.
1.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
2.
When Healthcare Chatbots Fall Short of Human Connection
3.
Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup
4.
A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.
5.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
1.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
2.
Revolutionizing Cancer Care with Fulphila: A New Hope for Patients
3.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
4.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
5.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part VII
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation